| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |